Evidence map›Paper›PMID 42570166›Full record

ArticleClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2026

Mapping the invisible: a Bayesian spatio-temporal analysis of male breast cancer mortality inequalities across Spanish provinces, 1999-2023.

Lucía Cayuela, José-Juan Pereyra-Rodríguez, Juan Carlos Rodríguez-Hernández, Francisco H Machancoses, Aurelio Cayuela

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Lucía CayuelaDepartment of Internal Medicine, Hospital Severo Ochoa, Leganés, Spain.ORCID http://orcid.org/0000-0003-1524-0501
José-Juan Pereyra-RodríguezDepartment of Medicine, University of Seville, Avda. Manuel Siurot S/N, 41013, Seville, Spain. jpereyra@us.es.ORCID http://orcid.org/0000-0001-6843-5877
Juan Carlos Rodríguez-HernándezDepartment of Dermatology, Virgen del Rocío University Hospital, Seville, Spain. j.carlos.her.rod@gmail.com.ORCID http://orcid.org/0000-0003-2525-4069
Francisco H MachancosesPredepartmental Unit of Medicine, Faculty of Health Sciences, Jaume I University, 12071, Castellón de La Plana, Spain.ORCID http://orcid.org/0000-0003-0280-5972
Aurelio CayuelaIndependent Researcher, Seville, Spain.ORCID http://orcid.org/0000-0002-4936-9402

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMale breast cancer (MBC) is a rare malignancy with marked geographic variation. This study presents the first nationwide spatio-temporal analysis of MBC mortality across Spain's 52 administrative units from 1999-2023.

methodsWe conducted an ecological spatio-temporal study analyzing 1,931 MBC deaths in Spain. Using indirect age standardization and 80 Bayesian hierarchical models, the best model incorporated Leroux spatial effects, first-order random walk temporal effects, and type II interaction. Model performance was evaluated using the Watanabe-Akaike information criterion and posterior predictive checks to estimate province-specific relative risks (RR) and posterior probabilities (PP) of excess risk.

resultsThe selected model demonstrated high predictive accuracy, with a root mean squared error of 4.65. Temporal effects accounted for most of the variability (51.5%). National mortality declined from an elevated risk in 1999 (RR 1.16; PP 0.96) to a reduced risk in 2023 (RR 0.89; PP 0.08). Spatial heterogeneity persisted, with excess risk concentrated in north-western Spain, particularly in A Coruña (period RR 1.23, 95% credible interval 1.02-1.48; PP 0.99). In contrast, Barcelona showed lower risk (RR 0.86, 95% credible interval 0.75-0.98; PP 0.01). Several provinces exhibited transient increases in risk around 2012-2013.

conclusionThe decline in Spanish MBC mortality marks a significant public health success. However, the persistent geographic inequality, particularly the excess risk in A Coruña, identifies a clear priority for future research. These findings offer a robust foundation for integrating clinical and genomic data to determine the drivers of these patterns and develop targeted interventions.

Indexed as

Bayesian hierarchical modelCancer mortalityGeographic inequalitiesMale breast cancerPublic health surveillanceSpainSpatio-temporal analysis

Identifiers

PMID42570166

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.